Recombivax HB

Recombivax HB

 [re-kom´bĭ-vaks″]
a trademark for a preparation of hepatitis B vaccine (recombinant).

Recombivax HB®

A recombinant hepatitis B vaccine. See Hepatitis B.
References in periodicals archive ?
Some of the major DNA vaccines include GlaxoSmithKline's Engerix-B, Twinrix, and Fendrix; Merck's Gardasil, and Recombivax HB; Protein Sciences Corporation's Flublok, etc.
Hepatitis (Recombivax HB, Havrix, Engerix-B), influenza (Fluarix, Fluzone, FluMist), polio (IPOL), malaria (RTSS), tuberculosis (BCG) are the some examples of anti-infective vaccines available in market.
Two are single-antigen vaccines--Engerix-B (GlaxoSmithKline Biologicals) and Recombivax HB (Merck & Co.)--and both can be used starting at birth.
of India Heberbiovac HB Hepatitis B CIGB-Heber Biotec Hepavax-Gene Hepatitis B Crucell Recombivax HB Hepatitis B Merck Revac-B Hepatitis B Bharat Biotech International Shanvac-B Hepatitis B Shanta Biotechnics Gardasil HPV Merck Cervarix HPV GSK Inflexal V Influenza Crucell HeberNasvac Hepatitis B The Cuban regulatory authorities Hecolin Hepatitis B Xiamen Innovax Biotech Vaccine Name Expression System Epaxal Cell-free GenHevac B Mammalian (CHO cells) Bio-Hep-B Mammalian (CHO cells) DTP-Hep B Yeast (P.
The two Heplisav doses are administered intramuscularly 1 month apart, compared with the 0-, 1-, and 6-month schedule for the two currently approved hepatitis B vaccines, Engerix-B and Recombivax HB. The two phase III noninferiority studies of healthy adults aged 1870 years compared immune response to vaccination with Heplisav (administered at 0 and 1 months, with a saline placebo administered at 6 months) in 3,778 adults, and with Engerix-B (administered at 0, 1, and 6 months) in 1,089 people.
The two Heplisav doses are administered intramuscularly 1 month apart, compared with the 0, 1, and 6 month schedule for the two currently approved hepatitis B vaccines, Engerix-B and Recombivax HB.
The most notable difference in the new guidelines is the recommendation that patients who do not respond to an initial series be revaccinated with a second 3-dose (Recombivax HB) or 4-dose (Energix-B[R], Smithkline Beecham Pharmaceuticals, Philadelphia, PA) course.
A single-antigen, preservative-free hepatitis B vaccine (Recombivax HB, pediatric) from Merck Vaccine Division (West Point, Pennsylvania) had earlier received similar approval [1].
2 Infants born to HBsAg-negative mothers should receive 2.5 mcg of Merck vaccine (Recombivax HB) or 10 mcg of SmithKline Beecham (SB) vaccine (Energix-B).
The commercial products available are Recombivax HB (Merck, West Point, PA) and Engerix-B (Smith Kline Beecham, Philadelphia, PA).
A study by MSD on its vaccine, Recombivax HB, states that induced protective levels of antibody occur in 96% of 1,213 healthy adults when injected into the deltoid muscle.[7] Among 1,149 vaccine recipients (17 to 68 years of age), 96% developed antibody titers between 1 and 2 months after the third dose.